OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers for Allogeneic HCT Outcomes
Djamilatou Adom, Courtney M. Rowan, Titilayo Adeniyan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning
Shannon R. McCurdy, Vedran Radojčić, Hua‐Ling Tsai, et al.
Blood (2021) Vol. 139, Iss. 4, pp. 608-623
Open Access | Times Cited: 65

Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology
Nicholas J Hess, David P Turicek, Jeremiah Riendeau, et al.
Science Advances (2023) Vol. 9, Iss. 12
Open Access | Times Cited: 16

Pre-transplant and transplant parameters predict long-term survival after hematopoietic cell transplantation using machine learning
Panagiotis G. Asteris, Amir H. Gandomi, Danial Jahed Armaghani, et al.
Transplant Immunology (2025), pp. 102211-102211
Closed Access

Nanoparticle-Based Biosensors for Salivary Analysis in Dentistry
Ali Doğan, Soley Arslan, Mustafa Nisair, et al.
IntechOpen eBooks (2025)
Closed Access

Reduced Enterohepatic Recirculation of Mycophenolate and Lower Blood Concentrations Are Associated with the Stool Bacterial Microbiome after Hematopoietic Cell Transplantation
Abdelrahman Saqr, Brooke Carlson, Christopher Staley, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 7, pp. 372.e1-372.e9
Open Access | Times Cited: 15

A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study
Geoff D.E. Cuvelier, Bernard Ng, Sayeh Abdossamadi, et al.
Blood Advances (2022) Vol. 7, Iss. 14, pp. 3612-3623
Open Access | Times Cited: 15

Recent advances in graft-versus-host disease
Aisling M. Flinn, Andrew R. Gennery
Faculty Reviews (2023) Vol. 12
Open Access | Times Cited: 8

Enzymatic Methods for Salivary Biomarkers Detection: Overview and Current Challenges
Alonso Ornelas‐González, Margarita Ortiz‐Martínez, Mirna González‐González, et al.
Molecules (2021) Vol. 26, Iss. 22, pp. 7026-7026
Open Access | Times Cited: 19

Novel therapies for graft versus host disease with a focus on cell therapies
Robert Zeiser, Olle Ringdén, Behnam Sadeghi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7

Chronic graft-versus-host disease detected by tissue-specific cell-free DNA methylation biomarkers
Batia Avni, Daniel Neiman, Elior Shaked, et al.
Journal of Clinical Investigation (2023) Vol. 134, Iss. 2
Open Access | Times Cited: 7

Biomarkers for acute and chronic graft versus host disease: state of the art
Luisa Giaccone, Danilo Faraci, Sara Butera, et al.
Expert Review of Hematology (2020) Vol. 14, Iss. 1, pp. 79-96
Open Access | Times Cited: 20

Management of Chronic Graft-vs.-Host Disease in Children and Adolescents With ALL: Present Status and Model for a Personalised Management Plan
Agnieszka Sobkowiak-Sobierajska, Caroline A. Lindemans, Tomáš Sýkora, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 10

Fecal β-glucuronidase activity differs between hematopoietic cell and kidney transplantation and a possible mechanism for disparate dose requirements
Mohammad H. Khan, Guillaume C. Onyeaghala, Armin Rashidi, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 9

Immune Monitoring After Allogeneic Hematopoietic Cell Transplantation: Toward Practical Guidelines and Standardization
Jaap Jan Boelens, Kinga Hosszu, Stefan Nierkens
Frontiers in Pediatrics (2020) Vol. 8
Open Access | Times Cited: 14

Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study
Philip L. McCarthy, Kristopher Attwood, Xiaojun Liu, et al.
Bone Marrow Transplantation (2023) Vol. 59, Iss. 3, pp. 334-343
Open Access | Times Cited: 4

18F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation
Jennifer Holter‐Chakrabarty, Lacey R. McNally, John E. Levine, et al.
Radiology Imaging Cancer (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1

Prospective external validation of biomarkers to predict acute graft-versus-host disease severity
Marie Robin, Raphaël Porcher, David Michonneau, et al.
Blood Advances (2022) Vol. 6, Iss. 16, pp. 4763-4772
Open Access | Times Cited: 7

Use of the NIH consensus criteria in cellular and soluble biomarker research in chronic graft-versus-host disease: A systematic review
Emina Milošević, Antonija Babić, Lorenzo Iovino, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5

Pretransplantation Plasma ST2 Level as a Prognostic Biomarker of 1-Year Nonrelapse Mortality in Allogeneic Hematopoietic Cell Transplantation
Lars Klingen Gjærde, Sisse Rye Ostrowski, Frederikke Schierbeck, et al.
Transplantation and Cellular Therapy (2022) Vol. 29, Iss. 2, pp. 97.e1-97.e6
Open Access | Times Cited: 5

Minnesota acute graft-<i>versus</i>-host disease risk score predicts survival at onset of graft-<i>versus</i>-host disease after post-transplant cyclophosphamide prophylaxis
Federica Ardizzoia, Francesca Lorentino, Alessandro Bruno, et al.
Haematologica (2022) Vol. 107, Iss. 11, pp. 2748-2751
Open Access | Times Cited: 4

A T-Cell Surface Marker Panel Predicts Murine Acute Graft-Versus-Host Disease
Carina A. Bäuerlein, Musga Qureischi, Zeinab Mokhtari, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 5

Acute GVHD: think before you treat
Laura F. Newell, Shernan G. Holtan
Hematology (2021) Vol. 2021, Iss. 1, pp. 642-647
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top